Chargement en cours...
Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance
The Total Therapy 3 trial 2003-33 enrolled 303 newly diagnosed multiple myeloma patients and was noted to provide superior clinical outcomes compared with predecessor trial Total Therapy 2, especially in gene expression profiling (GEP)–defined low-risk disease. We report here on the results of succe...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879104/ https://ncbi.nlm.nih.gov/pubmed/20124509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-255620 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|